The abstract is read at the publisher; the summary is JClub's.
About 20% of patients with haemodynamically severe pulmonary arterial hypertension achieved near-normal haemodynamics and safely de-escalated parenteral prostacyclin therapy.
- Why it matters: Continuous intravenous prostacyclin is effective but burdensome, and clinicians need strategies to maintain haemodynamic gains while reducing treatment intensity.
- What they did: The study evaluated outcomes in haemodynamically severe PAH patients treated with parenteral prostacyclins, focusing on the proportion reaching near-normal haemodynamics and the safety of prostacyclin de-escalation.
- The result: Early intensive treatment may help sustain near-normal haemodynamics after prostacyclin discontinuation, supporting treatment de-escalation in a subset of patients.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.